Resonance Health - be better informed Contact Us  |  Site Map  |  FAST Login
Resonance Health proudly delivers FerriScan for accurate assessing of body iron stores
Home About Us FerriScan HepaFat Scan Investors News & Events   Login


 

Welcome to Resonance Health

Resonance Health develops unique MRI image analysis software for the measurement of various liver conditions. 

FerriScan® provides an accurate estimate of liver iron concentration, critical in the management of patients with potentially fatal iron overload conditions. Regulatory cleared and used in over 20 countries.

HepaFat-Scan® provides a measurement of the amount of fat in the liver. Regulatory cleared and available for clinical use and for clinical trials requiring an assessment of liver fat.

Resonance Health is also in the research and development phase of an MRI based test for the assessment of liver fibrosis, which is showing promising results.

Resonance Health provide imaging core lab services for clinical trials. Its products and services are also available for the routine clinical management of patients.



Latest Content

24 May 2013
Use of FerriScan after HST transplant
The prestigious Fred Hutchinson Cancer Research Center in Seattle, USA has included FerriScan in it ...
More

24 Jan 2013
FerriScan cleared by FDA for marketing as a companion diagnostic

The US Food and Drug Administration today announced the authorisation of FerriScan to be markete ...
More

12 Sep 2012
FerriScan included in new international guidelines on Standards of Care
New guidelines that advocate the use of FerriScan have recently been produced by prestigi ...
More

Latest News

27 Aug 2014
Finalist in WA Innovator of the Year
Resonance Health has been shortlisted for WA Innovator of the Year for it's HepaFat-Scan Product
More

27 Aug 2014
HepaFat-Scan gains CE Mark and listing on the ARTG
HepaFat-Scan has now been listed on the Australian Register of Therapeutic Goods (ARTG) for use in Australia and has the CE Mark for use in Europe.
More

25 Mar 2014
Resonance Health gains FDA clearance for HepaFat-Scan
On 20 December 2013, Resonance Health received U.S. Food and Drug Administration 510(k) market clearance for HepaFat-Scan for the accurate measurement of the amount of fat in the liver using MRI.
More

FerriScan Centres Worldwide

Find out where FerriScan is available.







be better informed


Subscribe to Email Alerts